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Abstract Massive parallel sequencing has revolutionized
the search for pathogenic variants in the human genome,
but for routine diagnosis, re-sequencing of the complete
human genome in a large cohort of patients is still far too
expensive. Recently, novel genome partitioning methods
have been developed that allow to target re-sequencing to
specific genomic compartments, but practical experience
with these methods is still limited. In this study, we have
combined a novel droplet-based multiplex PCR method
and next generation sequencing to screen patients with
X-linked mental retardation (XLMR) for mutations in 86
previously identified XLMR genes. In total, affected males
from 24 large XLMR families were analyzed, including
three in whom the mutations were already known.
Amplicons corresponding to functionally relevant regions
of these genes were sequenced on an Illumina/Solexa
Genome Analyzer II platform. Highly specific and uniform
enrichment was achieved: on average, 67.9% unambigu-
ously mapped reads were derived from amplicons, and for
88.5% of the targeted bases, the sequencing depth was
sufficient to reliably detect variations. Potentially disease-
causing sequence variants were identified in 10 out of 24
patients, including the three mutations that were already
known, and all of these could be confirmed by Sanger
sequencing. The robust performance of this approach
demonstrates the general utility of droplet-based multiplex
PCR for parallel mutation screening in hundreds of genes,
which is a prerequisite for the diagnosis of mental retar-
dation and other disorders that may be due to defects of a
wide variety of genes.
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Introduction
The core problem of human and medical genetics is to
identify genetic variants underlying specific phenotypes.
This has been traditionally achieved by Sanger sequencing
of PCR products, which is a tedious process and often
economically formidable if a large set of genes needs to be
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studied. The situation has recently been improved dra-
matically with the emergence of massive parallel
sequencing technologies. Compared with the Sanger
method, these so-called next-generation sequencing plat-
forms can sequence DNA orders of magnitude faster and at
much lower cost (Mardis 2008; Shendure and Ji 2008).
However, even with the dramatically improved effi-
ciency, the current technology does not allow us to
re-sequence the complete genome from a large number of
human patients in an economically realistic manner (Olson
2007). Exploitation of the full potential of the current
platforms requires a subset of the genome of medical
interest to be isolated for targeted sequencing. To meet this
need, a variety of methods have been developed in the last
few years to carry out genome partitioning. Two recent
strategies include capture by circularization (Porreca et al.
2007) and selection by hybridization (Albert et al. 2007;
Hodges et al. 2007; Okou et al. 2007; Gnirke et al. 2009;
Ng et al. 2009; Turner et al. 2009). With different strengths
and weaknesses, nearly all of these strategies can be used
to enrich megabase-scale target regions. These can be
continuous genomic intervals or a full complement of
protein-coding exons (Albert et al. 2007; Hodges et al.
2007; Okou et al. 2007; Bau et al. 2009; Gnirke et al. 2009;
Ng et al. 2009; Turner et al. 2009).
Multiplex PCR is an option for enrichment of a set of
sequencing targets. However, given the challenges,
including primer dimer formation, mispriming, and non-
uniform amplification, the scale is often limited to a few
dozen targets in one reaction (Edwards and Gibbs 1994).
To circumvent these limitations, several derivative meth-
ods, such as Megaplex PCR and Nested Patch PCR have
been reported, where *100 targets were simultaneously
amplified and sequenced by using the Roche 454 platform
(Meuzelaar et al. 2007; Varley and Mitra 2008). Compared
with capture by hybridization or circularization these
attempts have achieved higher specificity and uniformity,
although their scales cannot match the ever-increasing
throughput of new sequencing technologies.
Very recently, a novel multiplex PCR method, which
uses emulsion PCR and a microfluidic chip to compart-
mentalize the PCR reactions by single primer pairs has
been developed. In their proof-of-principle experiment,
Tewhey et al demonstrated that up to 3,976 amplicons
could be simultaneously amplified (Tewhey et al. 2009).
Here, we applied this droplet-based PCR platform to
screen for mutations in 86 genes which are known to cause
X-linked mental retardation (XLMR) if mutated (Ropers
2007, 2008). We designed 1,912 amplicons to cover the
coding regions and flanking intronic regions. After
sequencing the PCR products obtained from 24 unrelated
patients with XLMR using the Illumina/Solexa platform,
three known causative mutations were confirmed and
another seven potential deleterious mutations were detec-
ted, including five missense changes, one frameshift
mutation and one 3 bp deletion. All these variants were
confirmed by traditional Sanger sequencing.
Results
In order to search for mutations in 86 known XLMR genes,
we applied a novel droplet-based multiplex PCR method to
simultaneously amplify their coding regions and splice
sites. In total, 1,315 target regions with a total length of
552,930 bp were identified in silico. After filtering the
regions for which suitable primers could not be found,
1,912 primer pairs were successfully designed to cover
1,198 target regions with a total length of 515,598 bp. The
size of the amplicons ranges from 201 to 600 bp, with an
average of 509 bp and a total length of 783,183 bp. Each of
the primer pairs was separately encapsulated into droplets.
These droplets were then pooled into a droplet primer
library. With a microfluidic platform (Tewhey et al. 2009)
the primer droplets were merged with droplets containing
fragmented genomic DNA, DNA polymerase and dNTPs
and dispensed into a single tube for PCR amplification.
The amplification products obtained from 24 patients
with XLMR were sequenced using the Illumina GAII
platform. More specifically, the products from each patient
were recovered by breaking the emulsion, then concate-
nated, and finally shotgun sequenced on one lane of the
Illumina flowcell. Single-end 36 nucleotide (nt) reads
generated from the shotgun library were aligned to the
human reference genome (NCBI build 36.1). Given our
alignment setting (see ‘‘Materials and methods’’), 474,504
of the 515,598 bp target sequences can be unambiguously
mapped using 36 nt reads.
For each of the 24 patients, an average of 402 Mb could
be unambiguously mapped to the reference genome
sequence (NCBI build 36.1), out of which 67.9% map
within the amplicons. The median sequence depth per base
within the target regions ranges from 92 to 445. To elim-
inate PCR artefacts introduced during the sequencing
library construction, we discarded all but one reads that
mapped exactly to the same region and on the same strand.
After this process, the median sequence depth ranges from
10 to 66. Between 94.1 and 99.6% of the target bases were
covered at least once and 87.9–99.5% were covered suffi-
ciently (base quality score C30; C29 coverage) to call
hemizygous mutations on the X chromosome from male
patients (see Table 1).
Uniformity of enrichment, together with specificity
determines the total amount of sequencing required to
achieve a coverage sufficient for reliable variation detec-
tion. The higher the difference in abundance between
42 HUGO J (2009) 3:41–49
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overrepresented and underrepresented targets, the more
sequencing will be required to cover all the target regions.
Here, from the lowest to the highest 10% quantile, the
depth per base pair differs up to 26-fold. 90% of the base
pairs have at least 29% of the average depth (Fig. 1a). Two
experimental procedures can generate this bias. On one
hand, due to the nature of massive parallel sequencing, it is
impossible to achieve an even distribution of sequencing
reads across the entire region. On the other hand, uneven
PCR amplification efficiency will result in different
amplicons with various abundances. Since the latter is
more relevant here, we also evaluated whether the
sequencing depth is uniform across amplicons. The
variation from the lowest to the highest 10% quantile does
not change significantly from what is observed at the base
pair level (25-fold). 90% of all amplicons are covered with
a depth higher than 23% the average value, which is
attained for *50% of the amplicons (Fig. 1b). To assess
the reproducibility of such amplification bias, we compared
the normalised sequence coverage per amplicon between
different samples. The bias between two samples was
remarkably similar (see Fig. 2) and the average pair-wise
correlation coefficient between individuals for base and
amplicon coverage is 0.84 and 0.90, respectively, indicat-
ing the variability in amplification efficiency is mostly
systematic instead of being stochastic. Potential causes of
Fig. 1 Normalised sequencing coverage distribution. a Normalised
coverage cumulative distribution of the sequenced bases within all
amplicons. b Normalised coverage cumulative distribution of all
amplicons. Normalised coverage is the absolute coverage divided by
the mean coverage. Amplicon coverage is the median coverage of all
the bases within the amplicon. Solid lines represent the average
among all the 24 samples and the dashed lines represent 25th and 75th
percentiles
Fig. 2 The correlation of
sequencing coverage between 2
samples. a The sequence
coverage of each base from
sample 1 was plotted against
sample 3. b. The sequence
coverage of each amplicon from
the same 2 samples was plotted.
The sequence coverage of an
amplicon is the median
sequence coverage of all bases
within the amplicon. The data
shown here are representative
for all 24 patients
44 HUGO J (2009) 3:41–49
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the variability could include GC content of the amplicon
and amplicon length. However, these factors do not have a
significant impact (see Fig. 3).
We called sequence variations including single nucleo-
tide variants (SNVs) and indels of 1–3 bp at positions with
sufficient sequence coverage (C29 coverage and Phred-
like quality score C30; for details, see ‘‘Materials and
methods’’). In 24 patients, we have identified 310 SNVs
and 27 small indels comprising 1–3 bp. Of these, 75 SNVs
and 16 indels were not represented in dbSNP (version 130).
The number of annotated and novel SNVs as well as indels
found in each individual is listed in Table 1. In total,, we
found 58 novel SNVs and 9 novel indels in exonic and
50-bp of flanking intronic regions. All 3 previously known
mutations were detected (see ‘‘Materials and methods’’). 7
other changes were also considered as potentially patho-
genic, including 5 missense changes predicted by PolyPhen
(Sunyaev et al. 2001) to be deleterious, a frameshift
mutation and a deletion of one amino acid. All 7 could be
confirmed by Sanger sequencing (see Table 2).
Discussion
We have applied a novel droplet-based multiplex PCR
method to enrich the coding regions of 86 known XLMR
genes. Using emulsion PCR and microfluidics, the PCR
reactions by individual primer pairs were compartmenta-
lised, thereby avoiding interference between different pri-
mer pairs. This study demonstrated that the method has
high specificity for selected regions and high uniformity
between different amplicons. Combined with massive
parallel sequencing, high sequence coverage of the target
regions was achieved. This allowed us to identify novel and
potentially disease-causing mutations in XLMR genes.
Compared to previously described enrichment methods
that are based on hybridisation, our approach is better
suited for capturing short, closely neighboring exons. One
obvious reason is that PCR amplification can be optimized
for unique target regions whereas selection by hybridisa-
tion approaches will have to carry adjacent sequences
together with real targets and thus reduce specificity. In the
Fig. 3 The dependence of
sequencing coverage of
amplicons on their GC content
(a) or amplicon length (b). The
amplicons were grouped
depending on their GC content
(a) or length (b), the distribution
of sequencing coverage within
each group is shown as boxplot
Table 2 List of the seven
potentially deleterious
mutations
Patient ID Mutation Gene Amino acid change
MPI-2 chrX 134907970T-[C SLC9A6 p.L188P
MPI-3 chrX 31132095-31132097delAAG DMD p.L1897del
MPI-8 chrX 73660933G-[A SLC16A2 p.R271H
MPI-10 chrX 70256689A-[G MED12 p.Y166C
MPI-11 chrX 21920673A-[G SMS p.Y328C
MPI-16 chrX 153323964-153323965delAG GDI1 p.396frameshift
MPI-22 chrX 153240569T-[C FLNA p.Q1484R
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approach used here, different amplicons are concatenated
for shotgun sequencing. Most reads comprising the ends of
different fragments cannot be mapped using current map-
ping strategies and thus although these reads are derived
from the amplicons, they are not included to calculate the
specificity of enrichment. Since we expect 14% percent of
the reads to belong to this category (36 nt single end reads
from amplicons of 500 bp), the 67.9%, i.e. the percentage
of sequencing reads derived from the amplicons, represents
the minimum specificity, although this is already well in
excess of the *50% reported by two recent studies
employing hybridisation approaches (Gnirke et al. 2009;
Ng et al. 2009). In addition to specificity, our approach has
less allelic bias since most alleles can be equally well
amplified in one PCR reaction. In contrast, selection by
hybridisation will capture less of an allele which is sig-
nificantly different from the reference sequence, e.g. large
deletions overlapping with the probes. Upon mutation
detection, this allelic bias can increase false negative rates,,
especially in heterozygotes.
Another advantage of the enrichment protocol used here
is that the representation of different amplicons appears to
be more uniform than obtained with other, previously
described methods, particularly those based on capture by
circularisation, although recently, their performance has
been improved (Turner et al. 2009). In this study, the
sequencing depth was 29% of the mean for 90% of the
targeted bases, and 80% of all bases were enriched to
abundances within a 26-fold range. Since this bias is lar-
gely systematic instead of being stochastic, it can be further
reduced by adjusting the relative proportion of different
primer pairs in the PCR reaction.
High coverage, along with high uniformity and speci-
ficity of this enrichment technique render it very suitable
for the reliable detection of sequence variants. We have
correctly called variants at up to 99.5% of the uniquely
mappable positions in the target regions. In addition to the
3 previously known mutations, we detected another seven
putatively deleterious changes.
XLMR is a very heterogeneous disorder, and although
more than 80 XLMR genes are already known, they
account only for a portion of all disease causing mutations
in MR families with unambiguous X-linkage. In a meta-
analysis of all mutations found so far in the large cohort of
families collected by the European Mental Retardation
Consortium which does not include patients with Fragile-X
syndrome, mutations in other known XLMR genes were
found to be responsible for at least 42% and likely to
account for even half of the XLMR families (de Brouwer
et al. 2007). Since our study includes additional XLMR
genes that were identified (Tarpey et al. 2009) after the
afore-mentioned analysis, we expected to find mutations in
an even higher proportion of families. However, this was
not the case: in the present study we detected putatitve and
possible mutations in no more than 7 out of 21 families
(33%). Several factors may account for this discrepancy.
First, our cohort was small (n = 21), and the statistical
power is therefore low. Second, our families were part of
the EuroMRX cohort, i.e. they were mutation-negative
‘‘leftovers’’ after the screening of a variable number of
XLMR genes by conventional Sanger sequencing. Third,
the coverage of the method employed here was not com-
plete: on average, 88.5% of all targeted exonic and 50 bp
flanking intronic sequences (515,598 bp) were covered at a
sufficient depth. With our alignment settings, 131 ampli-
cons cannot be unambiguously mapped and thus can not be
analyzed. In addition, 34 amplicons were not successfully
amplified in at least one of the 24 patients (see Supple-
mentary Table). These regions may harbour additional
point mutations. Most amplification failures are probably
due to technical reason. To rule out larger deletions
encompassing two or several exons, we have screened the
data for missing adjacent amplicons in one or a few
patients. No such clustering of missing amplicons was
observed in any of the patients. Finally, due to the limita-
tions of 36 nt single end sequencing, we were only able to
detect indels of 1–3 bp, and larger indels might well
account for some of the missing mutations.
It is, however, probable that in most mutation-negative
XLMR families, many of the missing causative mutations
are either hidden in the non-coding regions of known
XLMR genes, or the mutations are within X-chromosomal
genes which have hitherto not been implicated in mental
retardation, including sequences for non-coding RNA
(Mercer et al. 2008). In the near future, large-scale exon
enrichment and parallel sequencing will make it possible to
screen the coding regions of all X-chromosomal genes.
This will not only lead to the identification of additional
XLMR genes, but will also provide the basis for compre-
hensive diagnostic tests for XLMR families.
In conclusion, the results of the present study demon-
strate the power of droplet-based multiplex PCR and next-
generation sequencing of the amplification products for
parallel mutation screening in a large number of genes.
This paves the way for a dramatic improvement in diag-
nosing genetically heterogeneous disorders and to elucidate
novel disease genes.
Materials and methods
Patients
Twenty-four families with X-linked mental retardation
(XLMR) were selected from the cohort of families col-
lected by the European Mental Retardation consortium
46 HUGO J (2009) 3:41–49
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(EUROMRX; www.euromrx.com). In all families, the
affected members suffered from non-syndromic mental
retardation, and the pedigree structure was strongly sug-
gestive of an underlying X-linked gene defect. No causa-
tive gene defects were known for 21 of these 24 families.
In 11 families, linkage analysis had been performed pre-
viously, which provided additional evidence of an X-linked
disorder and indicated linkage intervals that were supposed
to harbour the mutated genes.
Three families (15, 18 and 24) were included in which
the underlying gene defects were already known: an
insertion of one nucleotide in JARID1C (c.202_203insC) in
family 15 (Jensen et al. 2005), a base pair exchange in
IL1RAPL1 (c.1460G[A) in family 18 (Tabolacci et al.
2006), and a base pair exchange in SLC6A8 (c.1661C[T)
in family 24 (Rosenberg et al. 2004).
Primer design
The primer library was designed using the manufacturer’s
design parameters (RainDance Technologies) and the Pri-
mer3 algorithm (http://frodo.wi.mit.edu/primer3/). All SNPs
from dbSNP build 129 were filtered from the primer selec-
tion region. Repeat masking was not performed on the input
regions to the primer design pipeline. The primer design
pipeline performed an exhaustive primer selection across all
of the regions submitted. The primer library design pipeline
defined 2,075 unique amplicons successfully designing
primers for 2,048 amplicons (98.7% success rate). 27
amplicons could not be designed based on the Primer3
parameter setting (amplicon GC content and primer Tm).
From the 2,048 amplicons 1,912 were selected for the final
design.
Droplet based multiplex PCR
Genomic DNA samples were first fragmented to 2–4 kb
using a nebulization kit (Invitrogen, K7025-05) following
the manufacturer’s recommended protocol. To prepare the
input DNA template mixture for targeted amplification,
1.5 lg of the purified Genomic DNA fragments were added
to 4.7 ll 109 High-Fidelity Buffer (Invitrogen, 11304-
029), 1.26 ll of MgSO4 (Invitrogen, 11304-029), 1.71 ll
10 mM dNTP (New England Biolabs, NO447S/L), 3.6 ll
Betaine (Sigma, B2629-50G), 3.6 ll of RDT Droplet Sta-
bilizer (RainDance Technologies, 30-00826), 1.8 ll dime-
thyl sulfoxide (Sigma, D8418-50 ml) and 0.72 ll 5 units/ll
of Platinum High-Fidelity Taq (Invitrogen, 11304-029).
The samples were brought to a final volume of 25 ll with
Nuclease Free Water.
PCR droplets were generated on the RDT1000 instru-
ment (RainDance Technologies, 20-01000). To process a
single sample the user placed onto the RDT1000 a single
tube containing 25 ll of Genomic DNA Template Mix, the
primer droplet library (RainDance Technologies) and a
disposable microfluidic chip (RainDance Technologies).
The primer droplet library consists of a collection of
individual primer droplets where each primer droplet
contains matched pairs of forward and reverse primer
(1.1 lM per primer) for each amplicon that is in the primer
library. The RDT1000 generated each PCR droplet by
pairing a single gDNA template droplet with a single pri-
mer droplet. The paired droplets flow past an electrode
embedded in the chip and are instantly merged together.
All of the resulting PCR droplets were automatically dis-
pensed as an emulsion into a PCR tube and transferred to a
standard thermal cycler for PCR amplification. Each single
sample generated more than 1,000,000 single plex PCR
droplets.
Samples were cycled in a Bio-Rad PTC-225 thermocy-
cler as follows: initial denaturation at 94C for 2 min; 55
cycles at 94C for 15 s, 58C for 15 s, 68C for 30 s; final
extension at 68C for 10 min and hold at 4C.
After PCR amplification the emulsion of PCR droplets
was broken to release each individual amplicon from the
PCR droplets. For each sample an equal volume of RDT
1000 Droplet Destabilizer (RainDance Technologies,
40-00830) was added to the emulsion of PCR droplets,
the sample was vortexed for 15 s and then spun in a
microcentrifuge at 12,000g for 10 min. The oil from
below the aqueous phase was carefully removed from the
sample. The remaining sample was then purified using a
MinElute column (Qiagen, 28004) following the manu-
facturer’s recommended protocol. The purified amplicon
DNA was then tested on an Agilent Bioanalyzer to
confirm that the amplicon profile matches the expected
histogram profile.
RainDance amplicon concatenation and shearing
The purified amplicons were chloroform extracted and
ethanol precipitated to remove Taq-polymerase that may
have remained bound to the ends of the amplicons. The
ends of the amplicons were blunt ended and phosphory-
lated by adding all of the purified DNA to 2.5 ll 109
Blunting Buffer (NEB, E1201), 2.5 ll 1 mM dNTP Mix
(NEB, E1201L) and sterile water to a total reaction vol-
ume of 25 ll. The reaction was incubated at 22C for
15 min and immediately heated to 70C for 5 min fol-
lowed by placement on ice for 10 min. The amplicons
were then concatenated using the NEB Quick Ligation kit
according to the manufacturer’s protocol. The chloroform
extraction was repeated as before and the resulting pellet
was resuspended in 100 ll of low TE. The sample was
then fragmented as described in the standard Illumina
workflow.
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DNA fragments were then repaired to generate blunt ends
by T4 polymerase and Klenow DNA polymerase, and
phosphorylated with T4 polynucleotide kinase. After add-
ing a single ‘A’ base to the 30 end of the DNA fragments
using Klenow exo (30 to 50 exo minus), we ligated Solexa
adaptors (with a ‘T’ overhang) with the DNA fragments
using DNA ligase. Ligated products (size range 150–
200 bp) were gel purified on 2% agarose, followed by 18
cycles of PCR-amplification. We measured the DNA con-
centration with a Nanodrop 7500 spectrophotometer, and a
1 ll aliquot was diluted to 10nM. Adaptor-ligated DNA
was hybridized to the surface of flow cells, and DNA
clusters were generated using the Illumina/Solexa cluster
station, followed by 36 cycles of sequencing on the Illu-
mina/Solexa 1G analyzer, in accordance with the manu-
facturer’s protocols.
Data analysis
Sequence reads were compiled using a manufacturer-pro-
vided computational pipeline consisting of the open source
Firecrest and Bustard applications (Illumina). All the reads
with low quality were removed and the remaining reads
were aligned onto human genome reference (NCBI36.1)
with SOAP2.20 (Li et al. 2008) allowing up to 2 mis-
matches and without gap. The uniquely mappable reads in
the alignment results were used to calculate the sequence
depth of target regions.
For mutation calling, to avoid PCR artefacts during
Solexa sequencing library construction, we removed all but
one read with the same mapping coordinate and strandness.
Sequence calls were then performed only on posi-
tions C29 coverage and Phred-like quality score C30. To
call hemizygous single nucleotide variants (SNV), the
minimum percentage of reads representing the specific
allele was required to be 70%. The SNVs were compared
with dbSNP (version 130) to identify the known SNPs. The
unknown SNVs were evaluated by PolyPhen for functional
effects (Sunyaev et al. 2001).
The sequencing reads that cannot be mapped using
SOAP2.20 were aligned onto human genome reference
(NCBI 36.1) using SOAP1.11, allowing a gap length of up
to 3 bp and without any mismatch. The uniquely mappable
reads were then used to construct the non-redundant
alignment as above. To call hemizygous indels, the mini-
mum percentage of reads representing the specific allele
was required to be 70%. The results were compared with
dbSNP (version130) to identify the known indels.
In order to assess the uniformity of enrichment, we
calculated the depth of sequencing coverage for all the
targeted positions except, the first and last 36 nt of each
amplicon as well as the positions without full mappability.
The reason for the removal of the terminal 36 nt on both
sides of one amplicon were that they were often found in
chimeric sequencing reads that comprised the ends of two
concatenated amplicons. Since the chimeric reads could
not be mapped using our alignment setting, the sequence
depths obtained for these positions were underestimated.
We also calculated the median depth of coverage for each
amplicon according to the base depth. The reproducibility
of the enrichment uniformity was evaluated by calculating
the average correlation coefficients of sequencing depth
across all pairwise comparisons.
The sequencing data have been deposited in NCBI Short
Reads Archive (SRA) with accession number SRA010105.
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